Trial Details
COMPLETEDBasic Information
| Clinical ID | c3947 |
|---|---|
| Identifier | NCT01284062 |
| Trial Title | Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | BIOLOGICAL: Anrukinzumab|BIOLOGICAL: Anrukinzumab|BIOLOGICAL: Anrukinzumab|OTHER: placebo |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2011-03 |
|---|---|
| Primary Completion Date | 2013-04 |
| Completion Date | 2013-04 |